P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.26 Billion | 1.04 Billion | 491.06 Billion | 485.54 Million | 145.48 Million | 87.69 Million |
| Cost of Revenue | 1.23 Billion | 1.14 Billion | 668.06 Million | 485.29 Million | 141.02 Million | - |
| Gross Profit | 31.63 Million | -95.01 Million | 490.39 Billion | 243.69 Thousand | 4.45 Million | 87.69 Million |
| Operating Expenses | 199.56 Million | 1.29 Billion | 519.65 Billion | 520.66 Million | 185.01 Million | 137.41 Million |
| Selling, General and Administrative Expenses | 125.59 Million | 162.4 Million | 54.89 Billion | 54.89 Million | 37.22 Million | 30.41 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 73.97 Million | 1.13 Billion | 464.75 Billion | 465.76 Million | 147.79 Million | -103.73 Thousand |
| Cost and Expenses | 1.43 Billion | 1.29 Billion | 519.65 Billion | 520.66 Million | 185.01 Million | 137.41 Million |
| Operating Income | -167.86 Million | -1.56 Billion | -31.41 Billion | -35.12 Million | -39.53 Million | -49.71 Million |
| Interest Expense | 15.98 Million | 11.4 Million | 10.67 Million | 2.53 Million | 2.53 Million | - |
| Income Tax Expense | 2.69 Million | 1.9 Million | -31.4 Billion | -3.99 Million | 2.63 Million | -6.01 Million |
| Earnings before Tax | -183.73 Million | -1.55 Billion | -31.41 Billion | -45.38 Million | -41.97 Million | -49.77 Million |
| Net Income | -57.77 Million | -270.12 Million | -10.08 Million | -31.41 Million | -41.97 Million | -43.8 Million |
| Earnings Per Share Basic | -0.61 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| Earnings Per Share Diluted | -0.20 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| Weighted Average Shares Outstanding | 94.88 Million | 41.57 Million | 41.57 Million | 39.53 Million | 47.58 Million | 68.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 294.59 Million | 41.57 Million | 41.57 Million | 39.53 Million | 47.58 Million | 68.15 Million |
| Gross Margin | 0.02 | -0.09 | 1.00 | 0.00 | 0.03 | 1.00 |
| EBIT Margin | -0.06 | -0.15 | -0.06 | -0.07 | -0.27 | -0.56 |
| Profit Margin | -0.05 | -0.26 | -0.00 | -0.06 | -0.29 | -0.50 |
| EBITDA | -81.07 Million | -1.46 Billion | -184.61 Million | -28.08 Million | -39.03 Million | -49.37 Million |
| Earnings Before Tax Margin | -0.13 | -1.49 | -0.06 | -0.07 | -0.27 | -0.57 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 379.15 Million | 388.48 Million | 346.86 Million | 1.26 Billion | 288.35 Million | 329.08 Million |
| Cost of Revenue | 386.86 Million | 403.59 Million | 389.31 Million | 1.32 Billion | 300.94 Million | 324.05 Million |
| Gross Profit | -7.7 Million | -15.1 Million | -42.45 Million | -55.04 Million | -12.59 Million | 5.03 Million |
| Operating Expenses | 23.62 Million | 28.72 Million | 21.8 Million | 112.82 Million | 322.17 Million | 350.11 Million |
| Selling, General and Administrative Expenses | 27.02 Million | 27.72 Million | 25.15 Million | - | 33.71 Million | 28.08 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.39 Million | -1 Million | 3.34 Million | 12.7 Million | 190 Thousand | -741 Thousand |
| Cost and Expenses | 410.49 Million | 432.31 Million | 411.12 Million | 1.43 Billion | 322.17 Million | 350.11 Million |
| Operating Income | -31.33 Million | -43.83 Million | -64.26 Million | -167.86 Million | -33.82 Million | -21.03 Million |
| Interest Expense | 5.43 Million | 4.25 Million | 4.04 Million | 15.98 Million | 4 Million | 3.85 Million |
| Income Tax Expense | 968 Thousand | 2.07 Million | 1.76 Million | 2.69 Million | 412 Thousand | 226 Thousand |
| Earnings before Tax | -27.8 Million | -47.53 Million | -67.34 Million | -183.73 Million | -36.87 Million | -27.35 Million |
| Net Income | -12.02 Million | -18.7 Million | -25.46 Million | -57.77 Million | -13.29 Million | -9.81 Million |
| Earnings Per Share Basic | -0.09 | -0.16 | -0.27 | - | -0.12 | -0.09 |
| Earnings Per Share Diluted | -0.09 | -0.16 | -0.09 | - | -0.04 | -0.09 |
| Weighted Average Shares Outstanding | 136.6 Million | 118.88 Million | 94.88 Million | 94.88 Million | 114.19 Million | 107.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 141.08 Million | 118.88 Million | 294.59 Million | 294.59 Million | 312.67 Million | 107.45 Million |
| Gross Margin | -0.02 | -0.04 | -0.12 | -0.04 | -0.04 | 0.02 |
| EBIT Margin | -0.03 | -0.06 | -0.12 | - | -0.04 | 0.00 |
| Profit Margin | -0.03 | -0.05 | -0.07 | -0.05 | -0.05 | -0.03 |
| EBITDA | -9.64 Million | -22.29 Million | -42.62 Million | - | -11.9 Million | 6000.00 |
| Earnings Before Tax Margin | -0.08 | -0.11 | -0.19 | -0.13 | -0.12 | -0.06 |
ML
SPFX
CONFRZ
002200
LBE
AOVTF